Empiric antibiotics discouraged
Consider risk factors for progression to severe disease
Inpatient Treatment Options
Remdesivir
Tocilizumab (Actemra®)
Baricitinib
Tofacitinib
Community-Acquired Pneumonia (CAP) Guideline